Low prevalence of anemia in inflammatory bowel disease: A population-based study in Sweden

Scandinavian Journal of Gastroenterology

Volumn 47, Issue 8-9, 2012, Pages 937-942

  Rejler, Martin ^a   Tholstrup, Jörgen ^a   Andersson Gäre, Boel ^b,c   Spångéus, Anna ^d  

^a Unit of Gastroenterology   (Sweden)

^b Futurum   (Sweden)

^c JÖNKÖPING UNIVERSITY   (Sweden)

^d LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anemia; Annual follow up; Hospitalization; Inflammatory bowel disease; Population based study quality; Prevalence

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; BODY MASS; CROHN DISEASE; DESCRIPTIVE RESEARCH; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; SWEDEN; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANALYSIS OF VARIANCE; ANEMIA; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SWEDEN; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84865758137     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2012.672590     Document Type: Article

References (24)

1. Dallman PR, Yip R, Johnson C. Prevalence and causes of anemia in the United States, 1976 to 1980. Am J Clin Nutr 1984;39: 437-45.
2. Goodnough LT, Nissenson AR. Anemia and its clinical consequences in patients with chronic diseases. Am J Med 2004;116(Suppl 7A): 1S-2S.
3. Stange EF, Travis SP, Vermeire S, Reinisch W, Geboes K, Barakauskiene A, et al. European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohns Colitis 2008;2: 1-23.
4. Travis S, Stange EF, Lémann M, Öresland T, Chowers Y, Forbes A, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut 2006;55(Suppl 1): i16-35.
5. Nikolaus S, Schreiber S. Diagnostics of inflammatory bowel disease. Gastroenterology 2007;133: 1670-89.
6. Ekbom A. The epidemiology of IBD: a lot of data but little knowledge. how shall we proceed? Inflamm Bowel Dis 2004; 10(Suppl 1): S32-4.
7. Gasche C. Anemia in IBD: the overlooked villain. Inflamm Bowel Dis 2000;6: 142-50; discussion 51.
8. Gomollon F, Gisbert JP. Anemia and inflammatory bowel diseases. World J Gastroenterol 2009;15: 4659-65.
9. Wilson A, Reyes E, Ofman J. Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature. Am J Med 2004;116(Suppl 7A): 44S-9S.
10. Porter ME, Baron J, Rejler M. Highland District Country Hospital: Gastroenterology Care in Sweden. Boston, MA USA: Harvard Business School; 2010.
11. Rejler M, Spangeus A, Tholstrup J, Andersson-Gare B. Improved population-based care: implementing patient-and demand-directed care for inflammatory bowel disease and evaluating the redesign with a population-based registry. Qual Manag Health Care 2007;16: 38-50.
12. Hjortswang H, Jarnerot G, Curman B, Sandberg-Gertzen H, Tysk C, Blomberg B, Almer S, Strom M. The short health scale: a valid measure of subjective health in ulcerative colitis. Scand J Gastroenterol 2006;41: 1196-203.
13. Stjernman H, Granno C, Jarnerot G, Ockander L, Tysk C, Blomberg B, Strom M, Hjortswang H. Short health scale: A valid, reliable, and responsive instrument for subjective health assessment in Crohn's disease. Inflamm Bowel Dis 2007;14: 47-52.
14. Gasche C, Berstad A, Befrits R, Beglinger C, Dignass A, Erichsen K, et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007;13: 1545-53.
15. Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am 2002; 31: 1-20.
16. Bager P, Befrits R, Wikman O, Lindgren S, Moum B, Hjortswang H, Dahlerup JF. The prevalence of anemia and iron deficiency in IBD outpatients in Scandinavia. Scand J Gastroenterol 2010;46: 304-9.
17. Schreiber S, Howaldt S, Schnoor M, Nikolaus S, Bauditz J, Gasche C, Lochs H, Raedler A. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. N Engl J Med 1996;334: 619-23.
18. Walker AM, Szneke P, Bianchi LA, Field LG, Sutherland LR, Dreyer NA. 5-Aminosalicylates, sulfasala-zine, steroid use, and complications in patients with ulcer-ative colitis. Am J Gastroenterol 1997;92: 816-20.
19. Dyer NH, Child JA, Mollin DL, Dawson AM. Anaemia in Crohn's disease. Q J Med 1972;41: 419-36.
20. Greenstein AJ, Kark AE, Dreiling DA. Crohn's disease of the colon. II. Controversial aspects of hemorrhage, anemia and rectal involvement in granulomatous disease involving the colon. Am J Gastroenterol 1975;63: 40-8.
21. Reilly J, Ryan JA, Strole W, Fischer JE. Hyperalimentation in inflammatory bowel disease. Am J Surg 1976;131: 192-200.
22. Wells CW, Lewis S, Barton JR, Corbett S. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis 2006;12: 123-30.
23. Ershler WB, Chen K, Reyes EB, Dubois R. Economic burden of patients with anemia in selected diseases. Value Health 2005;8: 629-38.
24. Pizzi LT, Weston CM, Goldfarb NI, Moretti D, Cobb N, Howell JB. Impact of chronic conditions on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis 2006;12: 47-52.